Table 3.
Frequency of preferred terminology classification of adverse events (AEs)
| Preferred term | Placebo (n = 98) | Robenacoxib (n = 95) | Total (n = 193) |
|---|---|---|---|
| Vomiting | 21 | 19 | 40 |
| Periodic* | 3 | 10 | 13 |
| Multiple* | 7 | 0 | 7 |
| Single occurrence | 11 | 9 | 20 |
| Anorexia | 4 | 8 | 12 |
| Lethargy | 7 | 3 | 10 |
| Diarrhea | 5 | 2 | 7 |
| Hiding | 1 | 3 | 4 |
| Weight loss | 2 | 1 | 3 |
| Hyposthenuria | 0 | 2 | 2 |
| Malaise | 0 | 2 | 2 |
| Stiffness | 0 | 2 | 2 |
Only AEs reported twice or more are shown
*
Periodic corresponds to vomiting occurring occasionally throughout the study; multiple corresponds to vomiting occurring more than once in a sequence over a period of time